Frontlight ResearchEarly access
Chronic myeloid leukaemia trials in Saudi Arabia
1 of 2 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleRWE,NIS,Prospective Study for the Effectiveness, Tolerability and Adherence of Asciminib in Saudi Arabia. (ASC4REAL)
- Where
- Dammam, Jeddah, Riyadh
- Age
- 18 years to 99 years
- People
- 40
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06684964